Influence of iron on growth and on susceptibility to itraconazole in Sporothrix spp

Alessandra Helena da Silva Hellwig1, Danielle Machado Pagani2, Iasmin da Silva Rios3

  • 1Postgraduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Rio Grande do Sul, Brazil.

Medical Mycology
|December 11, 2020
PubMed

Insights

Iron availability impacts Sporothrix spp. growth and oxidative stress susceptibility. Combining itraconazole with deferasirox showed limited synergistic effects against Sporothrix schenckii.

Area of Science:

  • Mycology
  • Medical Mycology
  • Antifungal Research

Background:

  • Sporothrix species are fungal pathogens causing sporotrichosis.
  • Iron is essential for fungal growth and virulence.
  • Antifungal resistance is a growing concern in treating sporotrichosis.

Purpose of the Study:

  • To investigate the effect of iron availability on Sporothrix spp. growth and oxidative stress.
  • To evaluate the antifungal activity of itraconazole in combination with deferasirox against Sporothrix spp.

Main Methods:

  • Sporothrix spp. isolates were cultured in media with varying iron concentrations.
  • Conidial susceptibility to oxidative stress was assessed.
  • Antifungal susceptibility testing was performed for itraconazole alone and with deferasirox.

Main Results:

  • Sporothrix brasiliensis growth was more sensitive to iron availability than Sporothrix schenckii.
  • Iron supplementation increased conidial susceptibility to oxidative stress in both species.
  • Synergistic antifungal effects between itraconazole and deferasirox were observed in a small subset of S. schenckii isolates.

Conclusions:

  • Iron metabolism plays a role in Sporothrix spp. pathogenesis and stress response.
  • Deferasirox, an iron chelator, does not broadly enhance itraconazole's efficacy against Sporothrix spp.
  • Further research into iron-targeted therapies for sporotrichosis may be warranted.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
270
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
552
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
93